πŸ‡ΊπŸ‡Έ FDA
Patent

US 11180499

Phosphodiesterase inhibitors

granted A61PA61P17/06A61P25/30

Quick answer

US patent 11180499 (Phosphodiesterase inhibitors) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P17/06, A61P25/30, A61P29/00